A hypertrophic scar is a cutaneous condition characterized by the excessive deposit of collagen within the boundaries of an original wound. Unlike keloids, which extend beyond the initial site of injury, hypertrophic scars remain confined to the area of trauma but are elevated, firm, and often erythematous. These scars typically develop within 4 to 8 weeks following a dermal injury, surgical incision, or burn. The pathogenesis involves a prolonged inflammatory phase during wound healing and an imbalance between collagen synthesis and degradation by fibroblasts and myofibroblasts. While they may regress spontaneously over a period of several years, they can cause significant functional impairment if they occur near joints, leading to contractures, or psychological distress due to their appearance.
Specify the exact anatomical location and laterality to ensure maximum coding accuracy and to support medical necessity for site-specific treatments.
Example: Patient presents with a 4 cm hypertrophic scar on the right dorsal forearm, resulting from a deep laceration six months ago. The scar is elevated, erythematous, and stays within the original wound boundaries. Documenting the specific location (right dorsal forearm) and laterality is essential for billing procedures like intralesional injections or laser therapy.
Billing Focus: Anatomical site specificity and laterality (e.g., right dorsal forearm).
Describe the physical characteristics of the scar, including elevation, color, and whether it remains within the boundaries of the original injury.
Example: Evaluation of the mid-sternal region reveals a linear, raised, firm, pink hypertrophic scar measuring 12 cm in length following a coronary artery bypass graft. The lesion does not extend beyond the surgical incision line. This documentation differentiates L91.0 from keloids (which extend beyond borders) and supports the severity of the cicatricial condition.
Billing Focus: Dimensions of the lesion in centimeters and descriptive morphology.
Document associated symptoms such as pruritus, pain, or tenderness, as these factors often justify the medical necessity of treatment over cosmetic concerns.
Example: The patient reports significant pruritus and occasional sharp pain associated with the hypertrophic scar on the left shoulder. The scar is 3 cm by 1 cm, raised 4 mm above the skin surface. Documenting these symptoms provides the clinical evidence required for insurance coverage of intralesional corticosteroid injections (CPT 11900).
Billing Focus: Symptomatic documentation (pain, pruritus) to distinguish from cosmetic-only requests.
Indicate any functional impairment or limitation in range of motion caused by the scar, especially when located near joints.
Example: A dense hypertrophic scar is noted over the left posterior popliteal fossa following a second-degree burn. The patient exhibits a 15-degree deficit in full knee extension due to skin tension from the scar. This functional limitation is critical for justifying complex surgical revisions or physical therapy.
Billing Focus: Documentation of functional loss or range of motion restrictions.
Record the etiology of the scar and any prior treatments attempted, such as silicone sheets or topical agents, to establish a chronic management history.
Example: Chronic hypertrophic scar on the right cheek following a motor vehicle accident 2 years ago. Patient has failed a 3-month trial of topical silicone gel and continues to experience social distress and lesion growth. This history of failed conservative therapy justifies the progression to more invasive procedural interventions.
Billing Focus: History of previous treatments and duration of the condition.
Appropriate for a quick follow-up or a simple visual check of a scar without new symptoms or complex treatment changes.
Standard code for managing a scar that requires active treatment like topical prescriptions or a brief procedural discussion.
Used when the patient has multiple scars, functional impairment, or if the physician must consider multiple therapeutic options like surgery or biologics.
The most common procedural treatment for L91.0 to flatten the scar and reduce symptoms.
Required when a patient has extensive scarring (e.g., post-acne or post-extensive burn) involving many discrete lesions.
Used for definitive removal of a small, bothersome hypertrophic scar.
Appropriate for scar revision in cosmetically or functionally sensitive areas like the neck or hands.
Used when the excision of a hypertrophic scar requires more than simple closure, involving extensive undermining or tissue rearrangement.
Commonly used for flattening scars or reducing vascularity without full excision.
Sometimes necessary for emerging laser technologies or combination therapies specifically targeting hypertrophic tissue.